Skip to main content

Karabelas Argeris N's Form 4 filing

REGENXBIO Inc.RGNX · filed Aug 5, 2024

Accession no.
0001562180-24-006015
Filed
Aug 5, 2024
Trade date
Aug 1, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $136.5K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Karabelas Argeris NCIK 0001191229Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2024Common StockMOption exerciseAcquired+10,000$3.76+$37,60021,286Direct
Aug 1, 2024Common StockMOption exerciseAcquired+100$12.74+$1,27421,386Direct
Aug 1, 2024Common StockSSaleDisposed−9,600$13.45F2−$129,12011,786Direct
Aug 1, 2024Common StockSSaleDisposed−400$14.59F3−$5,83611,386Direct
Aug 1, 2024Common StockSSaleDisposed−100$15.00−$1,50011,286Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 1, 2024Common StockMOption exerciseDisposed−100$0.00$01,400Direct
Aug 1, 2024Common StockMOption exerciseDisposed−10,000$0.00$020,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $13.20 to $14.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $14.44 to $14.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)